Pfizer hands PR for migraine drug launch to EMC
21 Aug 1998 | by SOPHIE BARKER
Pharmaceutical giant Pfizer has appointed EMC Euro PR to handle PR for the launch of its new migraine drug, Eletriptan, in Europe and the US.
Click
to remove filters
The Boots Company is reviewing its public affairs account which has been held by GJW for the past five years.
Pharmaceutical giant Pfizer has appointed EMC Euro PR to handle PR for the launch of its new migraine drug, Eletriptan, in Europe and the US.
Oxford Molecular, the company that supplies IT systems to pharmaceutical and biotech companies, has switched its financial PR account from Citigate Communications to Square Mile Communications.
Regester Larkin has won a three-way pitch to handle PR for the Community Pharmacy Action Group, as it continues its campaign to prevent the threatened abolition of resale price maintenance, a policy that guarantees a minimum price for over-the-counter medicine.
Pharmaceutical giant Smith-Kline Beecham has appointed GCI Prague to promote its consumer healthcare brands, which cover oral care and OTC medicines, in the Czech Republic. GCI is understood to have pitched against Ogilvy and Mather and Burson-Marsteller for the work.
The Royal Pharmaceutical Society of Great Britain, which represents pharmacists, has promoted public relations head Beverley Parkin to the new post of public affairs director. Her post was created during a reorganisation of the society, along with a new directorate of public affairs. The directorate...
KANSAS CITY: Pharmaceutical firm Hoechst Marion Roussel (HMR) has hired Cohn and Wolfe Healthcare to handle the global launch of its rheumatoid arthritis drug Arava.